Regulations.gov document
Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug…
Notice · FDA-2017-D-5767 · posted May 20, 2021
Key facts
| Document ID | FDA-2017-D-5767-0028 |
|---|---|
| Title | Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5767 |
| Posted | May 20, 2021 |
| Federal Register citation | 86 FR 27446 |
| FR document number | 2021-10603 |
| Comment period opens | May 20, 2021 |
| Effective date | May 20, 2021 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: